Vimarsana
Biggest News Aggregation in the World

Vance Thompson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vance Thompson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vance Thompson Today - Breaking & Trending Today

USD Alumnus Vance Thompson To Deliver Commencement Address May 4 - Vimarsana News

USD Alumnus Vance Thompson To Deliver Commencement Address May 4

VERMILLION — Vance Thompson ’82, ’86, M.D., founder of Vance Thompson Vision and director of refractive surgery and University of South Dakota alumnus, will deliver the commencement address at the

Vance Thomspon, MD, to take helm as ASCRS president - Vimarsana News

Vance Thomspon, MD, to take helm as ASCRS president

Thompson will assume the presidency of the ASCRS, which is celebrating its 50th anniversary in 2024. The organization kicks off its 2024 annual meeting Friday at Boston Convention and Exhibition Center in Boston.

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. - Vimarsana News

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

BERWYN, Pa.--(BUSINESS WIRE)--Jan 15, 2024--

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. - Vimarsana News

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by...

Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant) - Vimarsana News

Glaukos Announces FDA Approval of iDose® TR (travoprost intracameral implant)

Revolutionary, micro-invasive, injectable treatment for the full range of glaucoma disease severity iDose TR was designed to usher in a new era of interventional glaucoma by enabling a proactive...